Target intelligence / Profile preview

Activating blood circulation

Molecular classification
Therapeutic Principle, Pharmacological Category
01

Overview

Activating blood circulation, often referred to as 'Huoxue Huayu' in Traditional Chinese Medicine (TCM), is a therapeutic principle rather than a single molecular target such as a receptor or enzyme (PMC4145228). It describes a physiological effect or clinical strategy aimed at improving hemorheology, resolving blood stasis, and preventing the formation of thrombi. In modern pharmacological terms, this principle corresponds to anti-platelet, anti-thrombotic, and vasodilatory activities mediated by a variety of molecular pathways including the nitric oxide/cGMP pathway and the coagulation cascade (PubMed: 30554165). While various herbs like Salvia miltiorrhiza and synthetic drugs like Aspirin act through this principle, 'Activating Blood Circulation' does not represent a discrete protein or gene product. Consequently, it is categorized as an incorrect entry for a specific molecular target database but remains a vital concept in integrative pharmacology and drug discovery for cardiovascular health.

Other names
Blood-activating and stasis-removingHuoxue HuayuPromoting blood circulation and resolving blood stasisInvigorating blood
02

Mechanism of action

The mechanism involves multi-target modulation including the inhibition of platelet activation (e.g., via P2Y12 or COX-1 inhibition), enhancement of nitric oxide (NO) production for vasodilation, reduction of blood viscosity through fibrinogen regulation, and promotion of fibrinolysis to dissolve existing micro-thrombi (PMC4145228; PubMed: 28659473).

03

Biological functions

VasodilationInhibition of platelet aggregationAnticoagulationImprovement of microcirculationFibrinolysis
04

Disease associations

Cardiovascular diseaseThrombosisIschemic strokeInflammationDysmenorrheaAngina pectoris
05

Safety considerations

Risk of hemorrhageDrug-drug interactions with Western anticoagulantsGastrointestinal bleedingThrombocytopenia
06

Interacting drugs

Salvia miltiorrhiza (Danshen)

6 more in the full profile.

07

Biomarkers

Platelet aggregation rateD-dimerFibrinogen levelsProthrombin time (PT)Activated partial thromboplastin time (aPTT)

Beyond the preview

Go deeper on Activating blood circulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activating blood circulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call